Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features

Deng, MY; Sill, M; Chiang, J; Schittenhelm, J; Ebinger, M; Schuhmann, MU; Monoranu, C-M; ... Jones, DTW; + view all Deng, MY; Sill, M; Chiang, J; Schittenhelm, J; Ebinger, M; Schuhmann, MU; Monoranu, C-M; Milde, T; Wittmann, A; Hartmann, C; Sommer, C; Paulus, W; Gärtner, J; Brück, W; Rüdiger, T; Leipold, A; Jaunmuktane, Z; Brandner, S; Giangaspero, F; Nozza, P; Mora, J; Morales la Madrid, A; Cruz Martinez, O; Hansford, JR; Pietsch, T; Tietze, A; Hernáiz-Driever, P; Stoler, I; Capper, D; Korshunov, A; Ellison, DW; von Deimling, A; Pfister, SM; Sahm, F; Jones, DTW; - view fewer (2018) Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features. Acta Neuropathologica 10.1007/s00401-018-1865-4 . (In press).

https://ift.tt/2sf6xez